Diyabet tani ve tedavi rehberi 2017-12x21cm indd

KAYNAKÇA

---

143
TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
KAYNAKÇA
American College of Cardiology Foundation, and American Heart Association: 
Implications of recent clinical trials for the National Cholesterol Education 
Program Adult Treatment Panel III guidelines. Circulation 2004; 110 : 227-39
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M : Mortality from 
coronary heart disease in subjects with type 2 diabetes and in nondiabetic 
subjects with and without prior myocardial infarction. N Engl J Med 1998; 
339: 229– 34
Hansson L, Zanchetti A, Carruthers G, Dahlöf B, Elmfeldt DD, julius S, 
Menard J, Rahn KH, Wedel H, westerling S for the HOT Study Group: 
Effects of intensive blood pressure lowering and low-dose aspirin in 
patients with hypertension: principal results of the Hypertension Optimal 
Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–62
Heart Outcomes Prevention Evaluation Study Investigators: Effects of 
ramipril on cardiovascular and microvascular outcomes in people with 
diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. 
Lancet 2000; 355: 253–59
Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, 
Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group: 
Costs associated with the primary prevention of type 2 diabetes mellitus 
in the diabetes prevention program. Diabetes Care 2003; 26: 36-47
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, 
Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott 
MM, Hiatt WR: Peripheral arterial disease detection, awareness, and 
treatment in primary care. JAMA 2001; 286: 1317–24
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW: 10-Year 
followup of intensive glucose control in type 2 diabetes. N Engl J Med 
2008; 359: 1577-89.
IDF. Diabetes Atlas 2009, International Diabetes Federation, Brussels 2009
IDF Clinical Guidelines Task Force: Global Guidelines for Type 2 Diabetes. 
International Diabetes Federation, Brussels 2005
IDF. Guide for guidelines. A guide for clinical guideline development. 
International Diabetes Federation. Brussels 2003
International Expert Committee: International Expert Committee report on 
the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 
2009; 32: 1327- 34
Joint National Committee on detection, evaluation and treatment of 
high pressure. The seventh report of the Joint National Committee on 
prevention, detection and treatment of high blood pressure (The JNCVII 
report). JAMA 2003; 289(19): 2560-72.

---

TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
144
Jovanovic L: Diabetes Mellitus, Pregnancy, and Gestational Diabetes. In 
International Textbook of Diabetes Mellitus. De Fronzo RA, Ferrannini E, 
Keen H, Zimmet P, eds. John Wiley&Sons, Christer, UK 2004; 1563-77
Kawamura T: The importance of carbonhydrate counting in the treatment 
of children with diabetes. Pediatric Diabetes 2007; 8 (Suppl 6): 57-62
King H, Aubert RE, Herman WH:Global burden of diabetes, 1995–2025: 
prevalence, numerical estimates, and projections. Diabetes Care 1998; 
21: 1414–31.
Kitabchi AE, Umpierrez E, Murphy MB. Diabetic Ketoacidosis and 
hyperglycemic hyperosmolar state. In International Textbook of Diabetes 
Mellitus. DeFronzo RA, Ferrannini E, Keen H, Zimmet P, eds. John Wiles 
& Sons, Ltd, Chicester 2005; 1101-19
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA: Hyperglycemic 
crises in adult patients with diabetes. Diabetes Care 2006; 29: 2739- 48
Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan 
DR, Gun- derson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, 
Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, 
Rosenn BM, Thomas AM, Kirkman MS: Managing preexisting diabetes 
for pregnancy: summary of evidence and consensus recommendations 
for care. Diabetes Care 2008; 31: 1060-79.
Kulkarni K, Castle G, Gregory R, Holmes A, Leontos C, Powers M, 
Snetselaar L, Splett P, Wylie-Rosett J: Nutrition practice guidelines for 
type 1 diabetes mellitus positively affect dietitian practices and patient 
outcomes. J Am Diet Assoc 1998; 98: 62-70
Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, 
Smith AWM, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The 
British Diabetic Association Cohort Study, II: cause- specific mortality in 
patients with insulin-treated diabetes mellitus. Diab Med 1999; 16: 466-71
Lebovitz HE. Management of Hyperglycemia with Oral Antihyperglycemic 
Agents in Type 2 Diabetes. In Joslin’s Diabetes Mellitus. Kahn CR, 
Weir CR, King CL, Moses AC, Smith RC, Jacobson AM, eds. Lippincott 
Williams&Wilkins, 2006; 689-710
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, 
An Y, Shuai Y, Zhang B, Zhang J, Thomson TJ, Gerzoff RB, Roglic G, Hu 
Y, Bennett PH: The long-term effect of lifestyle interventions to prevent 
diabetes in the China Da Qing Diabetes Prevention Study: a 20- year 
follow-up study. Lancet 2008; 371(9626):1783-89